It is no secret that modern medicine is actively and often even successfully experimenting with various bioengineering projects in the context of implants. Today, a team of bio-implants and bioengineering specialists from Yale University together with colleagues from the medical company Humacyte presented the results of their research-observation, which showed that artificially created blood vessels, implanted into the patient’s circulatory system, can in fact become integral part of it. More precisely, experts have found that over time, the artificial fabric becomes quite natural.
This means that previous theories and hypotheses that artificially created blood vessels and blood transfer systems can effectively integrate into the natural circulatory system over time, to one degree or another. However, experts note that, observing how the cells of the natural environment and tissues inhabit the artificial, they noticed that this process lasts much longer than if the natural tissue restored itself.
However, the evidence of the transformation of artificial vascular tissue into the natural one revealed openly that practical bioengineering will soon be able to enter a qualitatively new level of development and offer potential patients a significantly higher level of efficiency of their implants. Of course, this will be preceded by some additional testing and experiments, which is also happening at this stage – however, it becomes clear that with an increase in the number of such experiments, the number of successfully completed projects grows.
Thus, specialists from Yale University, together with colleagues from Humacyte, lead to the fact that a successful experience with the natural cellular transformation of artificial blood vessels in the human body demonstrates new thresholds and directions of development of this technology in its time perspective – it remains only to wait for new news from Yale bioengineering fields .